Collegium Pharmaceutical Inc (COLL)
Net Income Growth
-225.60%
Quarterly · Period ending:
COLL Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-225.60%period ending
Latest reported-225.60%period ending
COLL Quarterly Net Income YoY % (2.09% → -225.60%)
Year-over-year change
High-resolution chart · PNG
COLL net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -225.6029% | |
| 499.7518% | |
| 35.3143% | |
| 237.5147% | |
| -38.881% | |
| -91.2785% | |
| -60.7514% | |
| -54.7591% | |
| 50.7342% | |
| 259.0325% | |
| 543.6727% | |
| 4,415.0985% | |
| 350.5683% | |
| -33.3384% | |
| 71.2431% | |
| -94.3202% | |
| -107.1263% | |
| -183.444% | |
| -459.7873% | |
| -28.7081% | |
| 803.9836% | |
| 3,380.4444% | |
| 416.129% | |
| 284.7438% | |
| 271.0102% | |
| 104.6392% | |
| -124.2241% | |
| 62.9802% | |
| 63.9204% | |
| 47.9949% | |
| 152.2094% | |
| -24.4213% | |
| 38.1658% | |
| 19.1784% | |
| 36.8518% | |
| 49.845% | |
| 13.8622% | |
| -47.435% | |
| -189.3333% | |
| -182.461% | |
| -424.6042% | |
| -323.7412% | |
| -174.5748% | |
| -42.8005% | |
| -13.5293% | |
| 2.0938% |